• About Us
  • Services
  • Process
  • News
  • Contact
BioPortUSA
  • About Us
    • Our Team
    • Advisory Board
    • Partners
    • Process
    • Client Experience
  • Services
    • Market Assessment
    • Market Launchpad
  • Process
  • News
    • Events
  • Contact
  • About Us
    • Our Team
    • Advisory Board
    • Partners
    • Process
    • Client Experience
  • Services
    • Market Assessment
    • Market Launchpad
  • Process
  • News
    • Events
  • Contact
28 Sep

BioPortUSA to Present to Swiss MedTech Delegation

Connecting Tomorrow - Swissnex The team at BioPortUSA has been asked to present to a group of 17 Swiss Medical Device start-ups on what it takes to be successful in the USA including how to navigate the regulatory pathway. “I am delighted to have been invited by Swissnex to present live to this delegation of Swiss Medtech companies who will be showcasing some of the newest and innovative technology to come out of Switzerland said Mark Lesselroth, CEO of BioPortUSA.” 

Swissnex is the world’s first science consulate whose vision is to help “unlock a new generation of ideas for Switzerland and the world of tomorrow.” Alicia Evangelista, Head of Innovation stated that  “we’re in the business of creating aha moments, working on the frontiers of education, research and innovation.” 

Given the vast network of resources BioPortUSA has at its disposal, they are in a unique position to help life science companies, including start-ups with helping get their technology commercialized in the United States.

Learn more about Swissnex

  • Facebook
  • Twitter
  • LinkedIn
  • Print
  • Email
Latest Articles
#
Medica Tech Forum
Nov 5, 2021, 9:58 AM
Zenit invites BioPortUSA to speak at MedTech conference
Nov 2, 2021, 11:51 AM
#
Swiss Start-Up engages BioPortUSA on help with Reimbursement
Oct 28, 2021, 11:44 AM

About BioPortUSA   

BioPort USA

The Gateway For Life Sciences Into The United States

Certification

akkreditiertes beratungsunternehmen

BioPortUSA is certified with RKW Thüringen.

Contact

United States

Mark Lesselroth, CEO

mark(at)bioportusa.com

+1 315 569 0642

BioPortUSA © 2021

About Us   Services    Process    Contact    Privacy